Less Ads, More Data, More Tools Register for FREE

Pin to quick picksDialight Regulatory News (DIA)

Share Price Information for Dialight (DIA)

Share Price is delayed by 15 minutes
Get Live Data
364.00    -1.00 (-0.27%)
Bid:
365.00
Ask:
378.00
Spread: 13.00 (3.562%)
Market Cap: £145.50m
DIA Live PriceLast checked at - London Stock Exchange

Intraday Dialight Share Chart

Holding(s) in Company

22 Jul 2009 15:57

RNS Number : 1161W
Dialight PLC
22 July 2009
Β 

ο»Ώ

TR-1: NOTIFICATION OF MAJOR INTEREST IN SHARES

1. Identity of the issuer or the underlying issuerΒ of existing shares to which voting rights areΒ attached:

Dialight PLC

2 Reason for the notificationΒ (please tick the appropriate box or boxes):

An acquisition or disposal of voting rights

YesΒ 

An acquisition or disposal ofΒ qualifyingΒ financial instruments which may result in theΒ acquisition of shares already issuedΒ to which voting rights are attached

NoΒ 

An acquisition or disposal of instruments with similar economic effect to qualifying financial instruments

Β No

An event changing the breakdown of voting rights

NoΒ 

Other (please specify):

NoΒ 

3. Full name of person(s) subject to theΒ notification obligation:

Β Aberforth Partners LLP

4. Full name of shareholder(s)Β (if differentΒ from 3.):

Shareholder Shares

Β 

1 Aberforth Smaller Companies Trust plc 2,922,422Β 

2 Aberforth UK Small Companies Fund 1,731,350 3 The Church Commissioners for England 645,700 4 Aberforth Geared Capital & Income Trust plc 578,145 1,2,4 = registered in the name of Nortrust Nominees Ltd A/c Aberforth, 3 = The Church Commissioners for England (Chase GIS) Nominees Ltd

5. Date of the transaction and date onΒ which the threshold is crossed orΒ reached:

20 July 2009Β 

6.Β Date on which issuer notified:

21 July 2009Β 

7. Threshold(s) that is/are crossed orΒ reached:

20%Β 

Β Β 

8. Notified details:

A: Voting rights attached to shares

Class/type of shares

if possible using the ISIN CODE

Situation previous to theΒ triggering transaction

Resulting situation after the triggering transaction

Number of Shares

Number of Voting Rights

Number of shares

Number of voting rights

% of voting rights

Direct

Direct

Indirect

Direct

Indirect

Β Ordinary Shares

Β 6,445,617

Β 6,445,617

Β 5,875,617

Β N/A

Β 5,875,617

Β N/A

Β 18.81%

Β 

B:Β QualifyingΒ Financial Instruments

Resulting situation after the triggering transaction

Type of financial instrument

Expiration date

Exercise/Β ConversionΒ Period

Number of voting rights that may be acquired if the instrument is exercised/ converted.

% of voting rights

Β N/A

Β N/A

Β N/A

Β N/A

Β N/A

C:Β FinancialΒ Instruments with similar economic effect to QualifyingΒ FinancialΒ Instruments

Resulting situation after the triggering transaction

Type of financial instrument

ExerciseΒ price

ExpirationΒ date

Exercise/ ConversionΒ period

Number of votingΒ rights instrumentΒ refers to

% of voting rights

Β 

Β 

Β 

Β 

Β 

Nominal

Delta

Β 

Β 

Total (A+B+C)

Number of voting rights

PercentageΒ of voting rights

Β 5,875,617

Β 18.81%

9. Chain of controlled undertakings through which the voting rights and/or the financial instruments are effectively held, if applicable:

Held by Aberforth Partners LLPΒ 

Proxy Voting:

10. Name of the proxy holder:

N/AΒ 

11. Number of voting rights proxy holder will ceaseΒ to hold:

N/AΒ 

12. Date on which proxy holder will cease to holdΒ voting rights:

N/AΒ 

13. Additional information:

N/AΒ 

14. Contact name:

Cathryn BuckleyΒ 

15. Contact telephone number:

01480 447490Β 

This information is provided by RNS
The company news service from the London Stock Exchange
Β 
END
Β 
Β 
HOLSEFFLESUSEDW
Date   Source Headline
10th Jun 20267:30 amRNSDirector Declaration
8th Jun 20267:00 amRNSHolding(s) in Company
2nd Jun 20267:00 amRNSNotice of Results & Investor Presentation
28th May 20267:00 amRNSHolding(s) in Company
26th May 20267:00 amRNSHolding(s) in Company
13th May 202612:52 pmRNSHolding(s) in Company
1st May 20267:00 amRNSTotal Voting Rights and Admission of Shares
1st Apr 20269:54 amRNSTransaction in Own Shares
30th Mar 20263:43 pmRNSDirector/PDMR Shareholding
25th Mar 20269:32 amRNSDirector/PDMR Shareholding
16th Mar 202610:41 amRNSIssue of Equity and Total Voting Rights
16th Mar 202610:41 amRNSIssue of Equity and Total Voting Rights
26th Feb 20266:32 pmRNSHolding(s) in Company
8th Jan 20267:00 amRNSThird Quarter Trading Update
12th Nov 20259:33 amRNSInvestor Presentation via Investor Meet Company
11th Nov 20254:55 pmRNSDirector/PDMR Shareholding
11th Nov 20257:00 amRNSFY26 Interim Results
6th Oct 20257:00 amRNSTrading Statement
30th Sep 20257:00 amRNSBlock listing Interim Review
16th Sep 20259:39 amRNSTotal Voting Rights
3rd Sep 20251:24 pmRNSHolding(s) in Company
2nd Sep 20253:34 pmRNSResult of AGM - Addendum
1st Sep 20253:21 pmRNSResult of AGM
1st Sep 20257:00 amRNSTrading Statement
14th Aug 20251:05 pmRNSHolding(s) in Company
11th Aug 202512:58 pmRNSHolding(s) in Company
1st Aug 20255:57 pmRNSHolding(s) in Company
1st Aug 20255:54 pmRNSHolding(s) in Company
1st Aug 20255:47 pmRNSHolding(s) in Company
1st Aug 20251:33 pmRNSHolding(s) in Company
14th Jul 20252:04 pmRNSNotice of AGM
14th Jul 202510:05 amRNSAnnual Financial Report
4th Jul 20257:00 amRNSDirector/PDMR Shareholding
3rd Jul 202510:18 amRNSDirector/PDMR Shareholding
24th Jun 202512:53 pmRNSDirector/PDMR Shareholding
24th Jun 20257:00 amRNSFinal Results
1st May 20254:04 pmRNSDirectorate Change
7th Apr 20254:50 pmRNSTotal Voting Rights
7th Apr 20254:44 pmRNSBlock listing Interim Review
31st Mar 20257:00 amRNSSanmina Final Agreement, Trading update
20th Mar 20255:49 pmRNSApplication for Block Listing
20th Mar 20257:00 amRNSDirector Declaration
19th Mar 20253:37 pmRNSDirector/PDMR Shareholding
18th Mar 20255:17 pmRNSDirector/PDMR Shareholding
14th Mar 20252:42 pmRNSHolding(s) in Company
4th Feb 20257:30 amRNSDirector Declaration
4th Feb 20257:00 amRNSHolding(s) in Company
28th Jan 20257:00 amRNSTrading Statement
10th Dec 20247:00 amRNSDirectorate Change
25th Nov 20247:00 amRNSHalf-year Report

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.